This section will connect you to the MMRF's Clinical Trials Monitor (CTM), a searchable database of the most promising trials in multiple myeloma. This interactive tool was designed to bring you the most current information about myeloma-specific clinical trials, some of which can only be found through our website. The CTM lists the most promising pharmaceutical and single institution trials, as well as trials that are sponsored by the National Cancer Institute and Cancer Cooperative Groups, and is searchable by type of trial, disease stage and geographic location

Patients who participate in clinical trials not only advance researchers' understanding of myeloma and how to most effectively treat the disease, but also gain access to the most innovative, cutting-edge treatment for multiple myeloma. In an effort to bring you to most current information on myeloma research, the MMRF updates the CTM on a regular basis.